{"name":"Medexus Pharma, Inc.","slug":"medexus-pharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"APVO101","genericName":"APVO101","slug":"apvo101","indication":"Advanced or metastatic solid tumors (Phase 3 development)","status":"phase_3"}]}],"pipeline":[{"name":"APVO101","genericName":"APVO101","slug":"apvo101","phase":"phase_3","mechanism":"APVO101 is a dual checkpoint inhibitor that blocks both PD-1 and CTLA-4 pathways to enhance anti-tumor immune responses.","indications":["Advanced or metastatic solid tumors (Phase 3 development)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNME03VVlLLXVHYW5aRlBGUWR4aGcxZ3pMRjhDY3RFaFpGWDZxRWNxdFpQeWdTeDVROE94TDIybTV5V2xBUjh2c2U4RkZXZU0tOXlBbzZrU2RONDdkb0dqZW9KenpkTVQ2YjR4czVWLXlnSmtGcWV0d190ZzZCTVZnNmFVVVhMX1gtM0huYWxfN2l4WE3SAZgBQVVfeXFMTThUeVk5clo1ZW4zS09ZSnlzcTBGZVJ6U2NDVm1QS2x5MFRmZzVqQ2ZGVkhpSFZ4LUVjcmctekRzN2t3TmhsRHhHUFg0OGk0cVYta0dXdXlMS283ejh2WnpKQ0dLTU90UnJ1bjFqdVNvWVV2bUp6STFZb2dzM011VWdkbmJqY0xuYjFDcFBPZUpJeVNUc3E0NHo?oc=5","date":"2026-02-17","type":"pipeline","source":"Cantech Letter","summary":"Analyst loves this Canadian specialty pharma stock - Cantech Letter","headline":"Analyst loves this Canadian specialty pharma stock","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxPSmR0dS1IT3I5Z2xvTGEwSUcyeFNlZjJ5V0FYV1RjanhERl9CYXZlR3lVMTUxX29ZSU5QX3pyeXQ3Y1RwcXRIYlRkWUZid2w1anVmVzFwcnhUN3dSNVpOZk56Wnp5X011eVEzM2xzSlJxYkMza1ljcC1ydF9FQzNJOWtlSmhGZWhDQ1dpdmVRTDRrZWt6NUUxSnB3aEVRaERDRXEyZEdNTGdCWE0tQnVXMl9ickVNdUltS1RIZW9jd21fUzYzQXVMOQ?oc=5","date":"2026-02-12","type":"earnings","source":"Investing.com","summary":"Earnings call transcript: Medexus Pharmaceuticals Q3 2026 sees revenue dip - Investing.com","headline":"Earnings call transcript: Medexus Pharmaceuticals Q3 2026 sees revenue dip","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQMFlXQ2NjaExzU3pKRWg4Tk84UjFQaElJcEtRdmxZMVF6cTJIb2lwMUI1Uk1YZ3YtSG1wbUJ1YkROb2JOV0tNTldiX3VXUW13V3NTNVpkeExaTVBtelJSZlBib1NJbGFtcFNPZzhQODBFRUJmNUxyTm5qRjlxTTM3UDBKaWgwb1QtMm1sN2NZMER6SVNlZ2kwR2p0QlcyaUF1Ync3ZE16QUVsTDVUQWNzX2ZMdFJWejhSN3ptUWRtTEY3Zw?oc=5","date":"2026-01-27","type":"pipeline","source":"Kalkine Media","summary":"Medexus Pharmaceuticals (TSX:MDP) Canada Commercialization Approach And Advantage - Kalkine Media","headline":"Medexus Pharmaceuticals (TSX:MDP) Canada Commercialization Approach And Advantage","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-30","type":"pipeline","source":"simplywall.st","summary":"Medexus Pharmaceuticals Inc.'s (TSE:MDP) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong? - simplywall.st","headline":"Medexus Pharmaceuticals Inc.'s (TSE:MDP) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Mar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOa1RVMXVRVmw5aW1XZ19nTmtqZzVSdFk0Wjhjckl2X0l2NzVIbHU0MVN5Z0x1V0ZoNGtub3JjR1QzZ21WN29fS1hrZXV5MWZoVlRXNy1WdENlNzRxLThZUV80eXZwUTRrY2RjcnpLbWxZOGFnci13MTc0N1c3cVBBTV9UcnZqMFFp?oc=5","date":"2025-09-25","type":"pipeline","source":"Yahoo Finance","summary":"Medexus Pharmaceuticals Inc. (TSE:MDP) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? - Yahoo Finance","headline":"Medexus Pharmaceuticals Inc. (TSE:MDP) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Sh","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-15","type":"earnings","source":"simplywall.st","summary":"Medexus Pharmaceuticals First Quarter 2026 Earnings: Beats Expectations - simplywall.st","headline":"Medexus Pharmaceuticals First Quarter 2026 Earnings: Beats Expectations","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiuAJBVV95cUxPaEdHeTNjS0JnQXlUZWNnbDJHd0c4NmY4N3V2QmtRck55cHY3MnhEbGdzaVIxZkxKQzY1eGVLSzN2VlBqVC1TakdQdXlJMVdiaVhLSHItRW1DUjY0aWwwQ1VuVTNoSEZvR1RsZWgwNWxyYm5xNHpoSGlpS3h6X3pLSFpHVkpGSzNPbnV2NlpVTnZBOXRnajNTWXdfU3VKNzZYZEJyZGRFREVnZmItQm5STWFzZkNta0ZvNHV4RG1RZ0NBMkZWaF9YbTU5azU1SHdseFVrLUZFTEVrRjA4ejBNdmVPSDgxeDJrY3dEODBjX0JDbGVManhlbWZCYTAyQ3NkcV9qa0lTRWxwVFZOdWMxakVHUkVVMUlqRjZlWmZNeEVvanVZSlFFancxVVZSMlNyM2FlYkh6TlA?oc=5","date":"2024-11-07","type":"earnings","source":"GuruFocus","summary":"Medexus Pharmaceuticals Inc (TSX:MDP) Q2 2025: Everything You Ne - GuruFocus","headline":"Medexus Pharmaceuticals Inc (TSX:MDP) Q2 2025: Everything You Ne","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYEFVX3lxTE50R3Fnc1ZqaHp3c0hoajFSZDM1MjhaSE5KLW1RNWZqQUU0Mm9GZzdtVTNYeGhfX2JCY0hRUmlDblpnYVd5LTZrbVVYMlppSU40RElRaEVSZllFcl9MS3lPYQ?oc=5","date":"2024-05-11","type":"pipeline","source":"MarketBeat","summary":"Medexus Pharmaceuticals (MDP) Stock Forecast and Price Target 2026 - MarketBeat","headline":"Medexus Pharmaceuticals (MDP) Stock Forecast and Price Target 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQWHIxVUNXWlNCZkRGVC05ZTc0WDdxcmlGcjlpSThlUm03anFqNnVnYTdSTlZlT0FQeS1EYzY2UWZKWEVBQy03ckozWndlcUo0eUJvb1ZBcnRaamMtTmpXQmNxR0ZZcldacEZITGQ0QjhScE1jZmN3NlZzQkZwOGljUVpHdlExTE5PcmJHTjRTemp4WEhrdXJTZzF6T181WHIybXNpRjRWc3hSdkd6TWlydkx3?oc=5","date":"2023-11-16","type":"pipeline","source":"Equity.Guru","summary":"Potential of Medexus Pharmaceuticals: Chris Parry gets into what investors are missing - Equity.Guru","headline":"Potential of Medexus Pharmaceuticals: Chris Parry gets into what investors are missing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTE80R1ZnY2ppRDlVelZTQ1BQMFhEbHh2LTNRalp6Y292Ym90ajU0aDRTSUZTRnU4cXhXYzRqLXlwYVJCYjN5a3Z6aGhVNzlOMHRXdmh5WlV6Tm9hWnJOaW5Db2VXMA?oc=5","date":"2023-04-01","type":"pipeline","source":"TradingView","summary":"MDP Forecast — Price Target — Prediction for 2027 - TradingView","headline":"MDP Forecast — Price Target — Prediction for 2027","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPT0c1bTVTSGZoM2p3Und6ZVU1bW92TXdGXzY0QnV6VVFaMWxCMWpCZDdaaDVHM0lKWGxaNWg4cm5fcTBnZzNqczMtX0hIUEdfVHhrYndkRzlPZ2JxTnFSd3ZLZzVKSjFjWkdYY0lqdkx1LVVfTklsU3NJRDhXcmpydEY3dTdXa2ZSWWdkaVM1N3FXc3JGbW8zVEdiVlJtaXM4SnZ6Vw?oc=5","date":"2023-03-29","type":"pipeline","source":"Streetwise Reports","summary":"Coverage Launched on Drug Co. With 140% Upside - Streetwise Reports","headline":"Coverage Launched on Drug Co. With 140% Upside","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gFBVV95cUxNNzY4UDdQYjBtQmJLMW8tUmYxcHhlY0VaNU50MWdiVmtmSWg0MlNJbTNxa2pERkgxRW4tOHV1ZURkY1JoTjV3eTR2akVlblVYMDF0MjVfQ0Q1M0tDRlZKYUZvbWhuamp0Qm1fanJIQ0RKNFg0UXJsdTF2bmRZV0UtcEtaVE5CZ0haX2JtU3FvMUpUTFdWNklJcFBVLXM3TVdoQks5WHJxOWZUZG5Ud29FWXJRY0tvSGEtdDUyN1d3dm5uQVItMm9vZ2QtWmFSUmd6bkE?oc=5","date":"2021-03-03","type":"pipeline","source":"Proactive financial news","summary":"Medexus Pharmaceuticals has a potential company-maker in Treosulfan - Proactive financial news","headline":"Medexus Pharmaceuticals has a potential company-maker in Treosulfan","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":7,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}